Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American clinical trial

American Journal of Kidney Diseases

Volumn 33, Issue 3, 1999, Pages 471-482

  Nissenson, A R ^a   Lindsay, R M ^a   Swan, S ^a   Seligman, P ^a   Strobos, J ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

End stage renal disease; Ferrlecit injection; Functional iron deficiency anemia; Hemodialysis; Iron; Iron deficiency anemia; Sodium ferric gluconate complex in sucrose

Indexed keywords

FERRIC GLUCONATE; IRON DEXTRAN; IRON LECITHIN COMPLEX; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; THORAX PAIN;

EID: 0033016059     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70184-8     Document Type: Article

References (38)

1. JP Loge RD Lange CV Moore Characterization of the anemia associated with chronic renal insufficiency Am J Med 24 1958 4 18
2. Medicare Intermediary Manual Health Care Financing Administration . Section 3907 1996
3. J Eschbach J Egrie M Downing Correction of anemia of end stage renal disease with recombinant human erythropoietin N Engl J Med 316 1987 73 78
4. N Berliner TP Duffy HT Abelson Approach to the adult and child with anemia R Hoffman EJ Benz Jr SJ Shattil B Furie HJ Cohen LE Silberstein Hematology: Basic Principles and Practice 1995 Churchill Livingstone Philadelphia, PA 287 325
5. Health Care Financing Administration 1995 Annual Report, End Stage Renal Disease Core Indicators Project December 1995 Department of Health and Human Services, Health Care Financing Administration, Office of Clinical Standards and Quality Baltimore, MD
6. AR Nissenson National cooperative rHuEPO study in patients with chronic renal failure: A phase IV multicenter study Am J Kidney Dis 18 suppl 1 1991 24 33
7. MJ Kleiner DB Van Wyck CJ Kaupke LF Kirlin The role of iron and other factors in patients unresponsive to EPO therapy Semin Dial 7 1994 288 292
8. National Kidney Foundation Study Group: NKF-DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure Am J Kidney Dis 30 suppl 3 1997 S192 S237
9. S Fishbane GL Frei J Maesaka Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation Am J Kidney Dis 26 1995 41 46
10. WH Hörl K Dreyling HB Steinhauer R Engelhardt P Schollmeyer Iron status of dialysis patients under rHuEPO therapy Contrib Nephrol 87 1990 78 86
11. IC Macdougall B Tucker J Thompson CRV Tomson LRI Baker AEG Raine A randomized controlled study of iron supplementation in patients treated with erythropoietin Kidney Int 50 1996 1694 1699
12. DB Van Wyck JC Stivelman J Ruiz LF Kirlin MA Katz DA Ogden Iron status in patients receiving erythropoietin for dialysis-associated anemia Kidney Int 35 1989 712 716
13. RL Wingard RA Parker N Ismail RH Hakim Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin Am J Kidney Dis 25 1995 433 439
14. S Fishbane V Ungureanu J Maesaka CJ Kaupke V Lim J Wish The safety of intravenous iron dextran in hemodialysis patients Am J Kidney Dis 28 1996 529 534
15. J Paull A prospective study of dextran-induced anaphylactoid reactions in 5745 patients Anaesth Intensive Care 15 1987 163 167
16. RD Hamstra MH Block AL Schocket Intravenous iron dextran in clinical practice JAMA 243 1980 1726 1731
17. JF Navarro JL Teruel F Liano R Marcep J Ortuno Effectiveness of intravenous administration of Fe-Gluconate-Na complex to maintain adequate body iron stores in hemodialysis patients Am J Nephrol 16 1996 268 272
18. JE Taylor N Peat C Porter AG Morgan Regular low-dose intravenous iron therapy improves response to erythropoietin in hemodialysis patients Nephrol Dial Transplant 11 1996 1079 1083
19. J Pascual JL Teruel F Liano A Sureda J Ortuno Intravenous Fe-Gluconate-Na for iron-deficient patients on hemodialysis Nephron 60 1992 121 (letter)
20. J Pascual JL Teruel E Liano A Sureda J Ortuno Sodium ferric gluconate complex given intravenously for iron deficiency in hemodialysis Clin Nephrol 35 1991 87 (letter)
21. V Allegra G Mengozzi A Vasile Iron deficiency in maintenance hemodialysis patients: assessment of diagnosis criteria and of three different iron treatments Nephron 57 1991 175 182
22. Amerling R, Cu GA, Dubrow A, Levin NW, Osheroff RJ: Complications during hemodialysis, in Nissenson AR, Fine RN, Gentile DE (eds): Clinical Dialysis. Norwalk, CT, Appleton & Lange, pp 235-267
23. AR Nissenson S Swan LL Lambrecht P Anderson S Schweitzer Ferric gluconate (FerrlecitÆ) is safe in hemodialysis patients who react to iron dextran J Am Soc Nephrol 7 1996 1460A (abstr)
24. G Faich J Strobos Sodium ferric gluconate complex in sucrose: Safer than iron dextran J Am Soc Nephrol 8 1997 192A (abstr)
25. KR Bridges PA Seligman Disorders of iron metabolism RI Handin SE Lux TP Stossel Blood: Principles and Practice of Hematology 1995 Lippincott Philadelphia, PA
26. GM Brittenham Disorders of iron metabolism R Hoffman EJ Benz SJ Shattil B Furie HJ Cohen LE Silberstein Hematology: Basic Principles and Practice 1995 Churchill Livingstone New York, NY
27. AR Nissenson J Strobos Iron deficiency in patients with renal failure Kidney Int 55 Suppl 69 1999 518 521
28. JV Stivelman Optimization of iron therapy in hemodialysis patients treated with rHuEPO Semin Dial 6 1993 59 69
29. RM Lindsay JA Burton N Edward JH Dargle CRM Prentice AC Kennedy Dialyzer blood loss Clin Nephrol 1 1973 29 34
30. RE Longnecker JA Goffinet ED Hendler Blood loss form maintenance hemodialysis Trans Am Soc Artif Internal Organs 20 1974 135 141
31. DE Muller-Wiefel H Sinn G Gilli K Scharer Hemolysis and blood loss in children with chronic renal failure Clin Nephrol 8 1977 481 486
32. J Eschbach JD Cook BH Scribner CA Finch Iron balance in hemodialysis patients Ann Intern Med 87 1977 710 713
33. MP Kooistra A van Es A Struyvenberg JJM Marx Iron metabolism in patients with anaemia of end-stage renal disease during treatment with recombinant human erythropoietin Br J Haematol 79 1991 634 639
34. G Dunea MA Swagel U Bodiwala JAL Arruda Intradialytic oral iron therapy Int J Artif Organs 17 1994 261 264
35. EG Anastassiades D Howarth J Howarth D Shanks HM Waters K Hyde CG Geary JA Liu Yin R Gokal Monitoring iron requirements in renal patients on erythropoietin Nephrol Dial Transplant 8 1993 846 853
36. M Kotaki K Uday M Henriquez S Blum M Dave Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin Clin Nephrol 48 1997 63 64
37. MC Linder KJ Schaffer M Hazegh-Azam CY Zhou TN Tran GM Nagel Serum ferritin: Does it differ from tissue ferritin? J Gastroenterol Hepatol 11 1996 1033 1036
38. JT Rogers Ferritin translation by interleukin-6: The role of sequences upstream of the start codons of the heavy and light subunit genes Blood 87 1996 2525 2537